Verrica Pharmaceuticals's total assets for Q4 2024 were $54.13M, an increase of 64.41% from the previous quarter. VRCA total liabilities were $63.99M for the fiscal quarter, a -4.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.